UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 15

 

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934.

 

001-11388

Commission File Number

 

 

 

VIVEVE MEDICAL, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Viveve Medical, Inc.

345 Inverness Drive South

Building B, Suite 250

Englewood, CO 80112

(720) 696-8100

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, $0.0001 par value per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

 

 
 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)

☒

Rule 12g-4(a)(2)

☐

Rule 12h-3(b)(1)(i)

☒

Rule 12h-3(b)(1)(ii)

☐

Rule 15d-6

☐

Rule 15d-22(b)

☐

 

Approximate number of holders of record as of the certification or notice date: 94

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Viveve Medical, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: February 6, 2023

By:

/s/ Scott Durbin
 

Name:

Scott Durbin
 

Title:

Chief Executive Officer

 

 

 

 
Viveve Medical (CE) (USOTC:VIVE)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Viveve Medical (CE) Charts.
Viveve Medical (CE) (USOTC:VIVE)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Viveve Medical (CE) Charts.